Drawing for COMMITMENT

USPTO serial 75256176

COMMITMENT

Reviewed by CopyMark Law Group

Status 603
Filing date
Status date
Registration date
Examiner
LEVINE, HOWARD B
Law office
TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with COMMITMENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
016newsletter on the subject of the work, mission and services of the cystic fibrosis foundationACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 13, 2006MAB3ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
May 26, 1999ABN3ABANDONMENT - AFTER EX PARTE APPEAL
May 26, 1999EXPTEXPARTE APPEAL TERMINATED
May 26, 1999EXFBEXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
May 26, 1999EXPIEX PARTE APPEAL-INSTITUTED
Aug 12, 1998CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 23, 1997CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 1997DOCKASSIGNED TO EXAMINER
Sep 19, 1997DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance